Peptide shows potential as an appetite suppressant - The Lancet

appetite and food intake in 12 obese and 12 lean individuals in a double-blind, placebo-controlled, crossover study. They found that obese patients given the hormone had a 30% lower caloric intake during a buffet lunch offered 2 hours after the infusion. Intake was also reduced by 31% in lean individuals. These reductions were sustained ... ................
................